Xeris Biopharma Holdings Inc (NASDAQ: XERS) kicked off on Tuesday, up 0.43% from the previous trading day, before settling in for the closing price of $4.64. Over the past 52 weeks, XERS has traded in a range of $2.03-$6.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 40.01% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 80.00%. With a float of $147.58 million, this company’s outstanding shares have now reached $156.01 million.
In an organization with 394 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 80.99%, operating margin of -10.11%, and the pretax margin is -21.41%.
Xeris Biopharma Holdings Inc (XERS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Xeris Biopharma Holdings Inc is 7.85%, while institutional ownership is 54.43%. The most recent insider transaction that took place on Jun 13 ’25, was worth 109,475. In this transaction an insider of this company bought 25,000 shares at a rate of $4.38, taking the stock ownership to the 1,708,585 shares. Before that another transaction happened on May 09 ’25, when Company’s Director proposed sale 56,667 for $4.90, making the entire transaction worth $277,668.
Xeris Biopharma Holdings Inc (XERS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.00% per share during the next fiscal year.
Xeris Biopharma Holdings Inc (NASDAQ: XERS) Trading Performance Indicators
Take a look at Xeris Biopharma Holdings Inc’s (XERS) current performance indicators. Last quarter, stock had a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.30, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.12 in one year’s time.
Technical Analysis of Xeris Biopharma Holdings Inc (XERS)
Let’s dig in a bit further. During the last 5-days, its volume was 2.3 million. That was inferior than the volume of 2.54 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 61.90%.
During the past 100 days, Xeris Biopharma Holdings Inc’s (XERS) raw stochastic average was set at 46.29%, which indicates a significant decrease from 73.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.63% in the past 14 days, which was lower than the 62.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.58, while its 200-day Moving Average is $3.82. However, in the short run, Xeris Biopharma Holdings Inc’s stock first resistance to watch stands at $4.74. Second resistance stands at $4.83. The third major resistance level sits at $4.92. If the price goes on to break the first support level at $4.56, it is likely to go to the next support level at $4.47. The third support level lies at $4.38 if the price breaches the second support level.
Xeris Biopharma Holdings Inc (NASDAQ: XERS) Key Stats
The company with the Market Capitalisation of 746.32 million has total of 156,385K Shares Outstanding. Its annual sales at the moment are 203,070 K in contrast with the sum of -54,840 K annual income. Company’s last quarter sales were recorded 60,120 K and last quarter income was -9,220 K.
